This Article Free Full Text Free Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Illanes, O. Articles by Jessen, B. A. Search for Related Content PubMed PubMed Citation Articles by Illanes, O. Articles by Jessen, B. A. Pubmed/NCBI databases Substance via MeSH Social Bookmarking                         What's this?

Retinal and Peripheral Nerve Toxicity Induced by the Administration of a Pan-Cyclin Dependent Kinase (cdk) Inhibitor in Mice

¹ Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California 92121, USA
³ MPI Research, Mattawan, Michigan 49071, USA

Correspondence: Address correspondence to: Bart Jessen, Pfizer Global Research and Development, 10777 Science Center Drive (CB4), San Diego, CA 92121; e-mail:bart.jessen{at}pfizer.com

Cyclin-dependent kinases (cdks) play a crucial role in cell cycle regulation and are considered promising targets for cancer therapy. Intravenous administration of AG-012986, a pan-cyclin-dependent kinase inhibitor (cdk_i), resulted in unexpected retinal and peripheral nerve toxicity in mice. AG-012986 was administered daily to CD-1 or B6C3F1 mice for 5 consecutive days. Mice were euthanized 24 h after the last dose (study day 6) or after a 21-day post-dose period (study day 26). Compound related microscopic findings were seen in the sciatic nerves (axonal degeneration) of both strains and in the retina (retinal degeneration/atrophy) of CD-1 mice only after the post-dose period. Although retinal degeneration/atrophy was not detected by routine histology in mice euthanized on day 6, apoptotic retinal cells were evident at this time using TUNEL assay. To our knowledge retinal or peripheral nerve toxicity secondary to the administration of cdk_is has not been previously reported. Although the pathogenesis of these lesions is unclear, the toxicities may reflect the unique profile of cdk inhibition, off-target kinase inhibition or receptor binding, or metabolism/distribution properties of AG-012986. Multi-targeted-inhibitors may interfere with cdks and other kinases involved in a wide range of functions other than cell cycle regulation, which could result in unexpected toxicities that may hinder their clinical applications.

Key Words: Cyclin-dependent kinase • retinopathy • peripheral neuropathy • mouse

Abbreviations: cdk_i, cyclin-dependent kinase inhibitor

Toxicologic Pathology, Vol. 34, No. 3, 243-248 (2006)
DOI: 10.1080/01926230600713186


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Zhang, K. Lundgren, Z. Yan, M. E. Arango, S. Price, A. Huber, J. Higgins, G. Troche, J. Skaptason, T. Koudriakova, et al. Pharmacologic properties of AG-012986, a pan-cyclin-dependent kinase inhibitor with antitumor efficacy Mol. Cancer Ther., April 1, 2008; 7(4): 818 - 828. [Abstract] [Full Text] [PDF]

				G. Saturno, M. Pesenti, C. Cavazzoli, A. Rossi, A. M. Giusti, B. Gierke, M. Pawlak, and M. Venturi Expression of Serine/Threonine Protein-Kinases and Related Factors in Normal Monkey and Human Retinas: The Mechanistic Understanding of a CDK2 Inhibitor Induced Retinal Toxicity Toxicol Pathol, December 1, 2007; 35(7): 972 - 983. [Abstract] [Full Text] [PDF]